COVID-19 vaccines effectiveness against symptomatic disease and severe outcomes, 2021–2022: a test-negative case

COVID-19 vaccines effectiveness against symptomatic disease and severe outcomes, 2021–2022: a test-negative case–control study

Published:2023-05 Issue: Volume:218 Page:84-91
ISSN:0033-3506
Container-title:Public Health
language:en
Short-container-title:Public Health

Author:

Brazete C.,Brazete J.,Alves F.,Aguiar A.^ORCID,Gonçalves A.M.,Cardoso M.,Sá L.,Gonçalves E.^ORCID,Pinto M.^ORCID,Duarte R.

Funder

Fundação para a Ciência e a Tecnologia

European Social Fund

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,General Medicine

Reference31 articles.

1. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis;Liu;Infect Dis Poverty,2021

2. Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies;Kow;Inflammopharmacology,2021

3. United Kingdom Government, Department of Health and Social Care, Office for National Statistics. Direct and indirect health impacts of COVID-19 in England: emerging Omicron impacts. [10th November 2022]; Available from: https://www.gov.uk/government/publications/direct-and-indirect-health-impacts-of-covid-19-in-england-emerging-omicron-impacts/direct-and-indirect-health-impacts-of-covid-19-in-england-emerging-omicron-impacts.

4. Analysis of the delta variant B.1.617.2 COVID-19;Shiehzadegan;Clin Pract,2021

5. Duration of protection against mild and severe disease by covid-19 vaccines;Andrews;N Engl J Med,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study;Journal of Infection;2023-12